We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The MHRA is providing an update on defects identified with Belzer solutions, manufactured by Carnamedica (UK Responsible Person Bridge to Life).
Carnamedica has identified issues with third-party suppliers, which could result in microbiological contamination, particulate matter within the solution, and leakage of fluid.
Risk minimisation materials are available to support the safe use of new paediatric formulations of rivaroxaban (Xarelto) and dabigatran etexilate (Pradaxa). In addition, we ask healthcare professionals to consult the current advice to ensure that all patients with renal impairment...
New contraindications, warnings, and advice for monitoring.
Following suspensions by some countries of the COVID-19 Vaccine AstraZeneca over suspected blood clots, the MHRA confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go and get their COVID-19 vaccine when...
Employment Tribunal decision.
Fluoroquinolones should only be used after careful benefit-risk assessment and after consideration of other therapeutic options in patients at risk for heart valve regurgitation (incompetence).
Venous and arterial pressure limits may be altered unintentionally following acknowledgement of the alarm in some haemodialysis and haemofiltration machines. If the cause of the alarm is not addressed, the machine may not re-alarm to alert the user to an...
Over £4 billion of government-wide investment will support shipyards, alongside new measures to drive the UK's shipbuilding future.
First published during the 2019 to 2022 Johnson Conservative government
Scientist Abi Spear explains how connections are one of the most important aspects of her incredible work in regenerative medicine.
The final of six new boats to improve support to Royal Navy divers has been delivered.
Two new support contracts have been secured for the Royal Navy’s versatile Offshore Patrol Vessels (OPVs).
First published during the 2022 to 2024 Sunak Conservative government
The Prime Minister will visit a Merseyside dockyard today as he announces a £4 billion injection into the UK’s regional shipbuilding industry.
DVLA announce total amount raised for Blood Bikes Wales and who staff voted as their Charity of Choice for 2022.
Canagliflozin may increase the risk of lower-limb amputation (mainly toes) in patients with type 2 diabetes. Evidence does not show an increased risk for dapagliflozin and empagliflozin, but the risk may be a class effect. Preventive foot care is important...
Dstl research shows that using blood products to treat severely injured patients before they reach hospital improves chances of survival.
David Willetts announces £48 million of new investment in biomedical research.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Manufactured by Becton Dickinson (BD) – tubes may contain a hole or be damaged or deformed, potentially causing blood leakage and/or an inadequate blood-to-additive ratio leading to incorrect test results.
Gadolinium-containing contrast agents are associated with a varying degree of risk of nephrogenic systemic fibrosis. See advice below to minimise risk in the following vulnerable groups: patients with renal impairment; patients in the perioperative liver transplantation period; infants, neonates, and...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).